Limited dissolution in gastrointestinal fluids restricts the fraction of luteolin that becomes available for absorption, contributing to its low and highly variable oral exposure
This escalating tolerance is one of the core limitations of GLP-1 therapy for patients needing significant weight loss (50+ lbs)
Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality
Even though GLP-1 medications suppress appetite, its important to consume adequate protein, vitamins, minerals, and overall calories to support your health
This decision should be made based on the patients health needs, the severity of the skin condition, and the benefits they are getting from semaglutide
GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats